Get the Stockscreener App
30.96
0.45%
-0.14
After Hours:
30.80
-0.16
-0.52%
Veracyte Inc Stock (VCYT) Latest News
Veracyte’s chief commercial officer John Leite sells $234,629 in stock By Investing.com - Investing.com Canada
Veracyte’s chief commercial officer John Leite sells $234,629 in stock - Investing.com
Veracyte (VCYT) Surged on Reporting Strong Earnings - Insider Monkey
Veracyte Inc to Host Earnings Call - accessnewswire.com
Shareholders Can Be Confident That Veracyte's (NASDAQ:VCYT) Earnings Are High Quality - Simply Wall St
29,779 Shares in Veracyte, Inc. (NASDAQ:VCYT) Purchased by Proficio Capital Partners LLC - Defense World
Veracyte at Raymond James Conference: Strategic Expansion and Growth By Investing.com - Investing.com Australia
Insider Sell: Phillip Febbo Sells Shares of Veracyte Inc (VCYT) - GuruFocus.com
Veracyte at Raymond James Conference: Strategic Expansion and Growth - Investing.com
Principal Financial Group Inc. Has $1.29 Million Stock Holdings in Veracyte, Inc. (NASDAQ:VCYT) - Defense World
Veracyte Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Veracyte, Inc. (NASDAQ:VCYT) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough - Simply Wall St
Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by Truist Financial Corp - Defense World
Veracyte's (NASDAQ:VCYT) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance
Veracyte (NASDAQ:VCYT) Stock Price Expected to Rise, UBS Group Analyst Says - MarketBeat
Veracyte (NASDAQ:VCYT) Given Buy Rating at Needham & Company LLC - MarketBeat
ARK Investment Management LLC Reduces Holdings in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte (NASDAQ:VCYT) Trading 9.9% Higher on Analyst Upgrade - MarketBeat
Guggenheim Reaffirms Buy Rating for Veracyte (NASDAQ:VCYT) - MarketBeat
Phocas Financial Corp. Reduces Stake in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte (NASDAQ:VCYT) Shares Gap Down Following Weak Earnings - MarketBeat
VERACYTE, INC. SEC 10-K Report - TradingView
Rhumbline Advisers Purchases 675 Shares of Veracyte, Inc. (NASDAQ:VCYT) - Defense World
StockNews.com Downgrades Veracyte (NASDAQ:VCYT) to Hold - Defense World
Veracyte (NASDAQ:VCYT) Cut to "Hold" at StockNews.com - MarketBeat
Investor Network: Veracyte Inc to Host Earnings Call - ACCESS Newswire
Veracyte’s Strong Market Position and Growth Potential Drive Buy Rating - TipRanks
Ieq Capital LLC Acquires New Shares in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte (NASDAQ:VCYT) Earns Buy Rating from Needham & Company LLC - Defense World
Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by State of New Jersey Common Pension Fund D - MarketBeat
Principal Securities Inc. Acquires 485 Shares of Veracyte, Inc. (NASDAQ:VCYT) - Defense World
UBS Group Forecasts Strong Price Appreciation for Veracyte (NASDAQ:VCYT) Stock - Defense World
Veracyte (NASDAQ:VCYT) Announces Quarterly Earnings Results - MarketBeat
D.A. Davidson & CO. Buys Shares of 23,354 Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte Shares Surge Amid Financial Success and Challenges - TipRanks
Veracyte (NASDAQ:VCYT) Shares Gap Down on Disappointing Earnings - Defense World
Veracyte Inc. Reports Strong 2024 Earnings Amid Challenges - TipRanks
Needham maintains Veracyte stock Buy rating, $51 target By Investing.com - Investing.com Canada
A Glimpse Into The Expert Outlook On Veracyte Through 5 Analysts - Benzinga
Veracyte Enters Oversold Territory (VCYT) - Nasdaq
Veracyte (VCYT) Q4 Earnings and Revenues Beat Estimates - MSN
Veracyte, Inc. (NASDAQ:VCYT) Q4 2024 Earnings Call Transcript - MSN
Solid Growth, Soft Outlook: Why I’m Holding On Veracyte (NASDAQ:VCYT) - Seeking Alpha
Diagnostic Company Veracyte Weighs Sale For French Subsidiary, Analyst Says 'Walking Away' Is A Long-Term Positive - Benzinga
Veracyte Stock Falls Despite Q4 Earnings and Revenue Beat - MSN
Thyroid Cancer Diagnostics Market to Reach USD 4.81 Billion by 2032, Growing at 5.65% CAGR – SNS Insider - GlobeNewswire
Earnings call transcript: Veracyte Q4 2024 earnings beat but stock dips By Investing.com - Investing.com South Africa
Needham maintains Veracyte stock Buy rating, $51 target - Investing.com India
Veracyte Inc (VCYT) Q4 2024 Earnings Call Highlights: Record Rev - GuruFocus.com
Veracyte Inc (VCYT) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Yahoo Finance
Veracyte Inc (VCYT) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Veracyte: Q4 Earnings Snapshot - The Washington Post
Veracyte exploring external buyers for divestiture of French unit’s activities - TipRanks
Veracyte, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
3.20%
1.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):